Compounds > 16-fluoroestradiol
Page last updated: 2024-08-24

16-fluoroestradiol and Carcinoma, Ductal, Breast

16-fluoroestradiol has been researched along with Carcinoma, Ductal, Breast in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Greenspan, D; Lebron, L; Pandit-Taskar, N1
Apollonio, G; de Vries, EF; Dierckx, RA; Glaudemans, AW; Hospers, GA; Schröder, CP; Venema, CM1

Reviews

2 review(s) available for 16-fluoroestradiol and Carcinoma, Ductal, Breast

ArticleYear
PET Imaging of Breast Cancer: Role in Patient Management.
    PET clinics, 2015, Volume: 10, Issue:2

    Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals

2015
Recommendations and Technical Aspects of 16α-[18F]Fluoro-17β-Estradiol PET to Image the Estrogen Receptor In Vivo: The Groningen Experience.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:11

    Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Estradiol; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Receptors, Estrogen

2016